HK Stock MarketDetailed Quotes

02367 GIANT BIOGENE

Watchlist
  • 48.000
  • +0.100+0.21%
Not Open Apr 24 16:08 CST
47.76BMarket Cap29.81P/E (TTM)

GIANT BIOGENE Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q6)Jun 30, 2023
(FY)Dec 31, 2022
(Q6)Jun 30, 2022
(FY)Dec 31, 2021
(FY)Dec 31, 2020
(FY)Dec 31, 2019
Cash flow from operating activities
Earning before tax
51.16%775.58M
21.05%1.18B
--513.09M
-0.03%972.92M
43.76%973.24M
--677M
Profit adjustment
Interest (income) - adjustment
-256.57%-23.76M
-39.87%-13.16M
---6.66M
4.80%-9.41M
38.93%-9.88M
---16.18M
Impairment and provisions:
157.66%316K
139.29%469K
---548K
110.72%196K
-216.20%-1.83M
--1.57M
-Impairmen of inventory (reversal)
261.60%648K
-11.54%-145K
---401K
-120.00%-130K
18.18%650K
--550K
-Impairment of trade receivables (reversal)
-6.31%-337K
-402.08%-145K
---317K
-80.41%48K
-25.30%245K
--328K
-Other impairments and provisions
-97.06%5K
173.02%759K
--170K
110.21%278K
-491.38%-2.72M
--696K
Revaluation surplus:
-391.41%-15.19M
157.21%8.28M
--5.21M
90.65%-14.47M
-95,441.98%-154.78M
---162K
-Other fair value changes
-391.41%-15.19M
157.21%8.28M
--5.21M
90.65%-14.47M
-95,441.98%-154.78M
---162K
Asset sale loss (gain):
-16.95%2.37M
1,501.10%2.91M
--2.86M
-21.55%182K
4,540.00%232K
--5K
-Loss (gain) on sale of property, machinery and equipment
-16.95%2.37M
720.85%2.91M
--2.86M
53.02%355K
4,540.00%232K
--5K
-Loss (gain) from selling other assets
----
----
----
---173K
----
----
Depreciation and amortization:
21.00%16.87M
14.12%27.63M
--13.94M
8.61%24.21M
24.66%22.29M
--17.88M
-Depreciation
21.88%16.13M
14.41%26.2M
--13.24M
8.54%22.9M
25.50%21.09M
--16.81M
-Amortization of intangible assets
4.55%735K
9.06%1.43M
--703K
9.77%1.31M
11.45%1.2M
--1.07M
Financial expense
--57K
--21K
----
----
----
----
Exchange Loss (gain)
-904.39%-15.04M
166.86%14.45M
--1.87M
---21.61M
----
----
Special items
26.47%10.43M
7.13%17.66M
--8.25M
2,684.97%16.49M
--592K
----
Operating profit before the change of operating capital
39.71%751.63M
27.62%1.24B
--538.01M
16.71%968.5M
22.02%829.87M
--680.11M
Change of operating capital
Inventory (increase) decrease
54.41%-3.24M
-283.44%-94.36M
---7.12M
-70.38%-24.61M
-50.53%-14.44M
---9.6M
Accounts receivable (increase)decrease
-333.20%-21.26M
67.43%-3.64M
--9.12M
-112.96%-11.16M
293.19%86.12M
---44.58M
Accounts payable increase (decrease)
389.98%55.53M
292.22%31.3M
--11.33M
-134.11%-16.28M
92.49%47.74M
--24.8M
prepayments (increase)decrease
108.91%11.16M
-219.48%-61.75M
---125.18M
-309.23%-19.33M
-84.70%9.24M
--60.37M
Cash  from business operations
89.45%794.18M
21.27%1.1B
--419.21M
-4.67%910.66M
33.42%955.26M
--715.96M
Other taxs
6.04%-101.29M
20.87%-172.7M
---107.8M
-80.18%-218.26M
-103.57%-121.13M
---59.51M
Special items of business
105.34%372K
-123.87%-3.23M
---6.96M
514.93%13.54M
-167.22%-3.26M
--4.85M
Net cash from operations
122.50%692.9M
34.55%931.64M
--311.41M
-16.99%692.4M
27.06%834.12M
--656.46M
Cash flow from investment activities
Interest received - investment
256.57%23.76M
39.87%13.16M
--6.66M
-4.80%9.41M
-38.93%9.88M
--16.18M
Loan receivable (increase) decrease
----
----
----
-13.33%201.31M
1,364.34%232.27M
--15.86M
Sale of fixed assets
--50K
----
----
----
----
----
Purchase of fixed assets
-338.82%-186.96M
-103.55%-152.66M
---42.61M
0.67%-75M
11.66%-75.51M
---85.47M
Selling intangible assets
----
----
----
--16.53M
----
----
Purchase of intangible assets
----
98.38%-586K
---526K
-4,286.91%-36.19M
97.20%-825K
---29.44M
Sale of subsidiaries
--33.13M
----
----
----
----
----
Recovery of cash from investments
5.25%603.92M
-72.44%1.48B
--573.81M
22.17%5.37B
346.80%4.4B
--984.2M
Cash on investment
-32.70%-946.3M
43.97%-2.2B
---713.1M
22.80%-3.93B
-240.96%-5.08B
---1.49B
Net cash from investment operations
-168.78%-472.4M
-154.93%-858.74M
---175.76M
399.98%1.56B
11.65%-521.12M
---589.85M
Net cash before financing
62.55%220.49M
-96.77%72.9M
--135.65M
620.65%2.26B
369.90%313.01M
--66.61M
Cash flow from financing activities
Issuing shares
----
1,023,592.98%583.51M
----
--57K
----
----
Dividends paid - financing
----
85.59%-367.46M
---367.46M
-169,335.22%-2.55B
---1.51M
----
Absorb investment income
-98.35%4M
-96.53%245.89M
--241.89M
78,723.44%7.09B
50.00%9M
--6M
Issuance expenses and redemption of securities expenses
99.80%-12.44M
-1,990,828.66%-6.25B
---6.24B
---314K
----
----
Other items of the financing business
---531K
99.73%-186K
----
-173.04%-68.31M
-206.44%-25.02M
---8.16M
Net cash from financing operations
99.86%-8.98M
-229.36%-5.79B
---6.36B
25,640.97%4.48B
-709.75%-17.52M
---2.16M
Effect of rate
135.33%15.04M
-1,485.12%-55.18M
---42.57M
--3.98M
----
----
Net Cash
103.40%211.52M
-184.93%-5.72B
---6.23B
2,178.04%6.73B
358.49%295.48M
--64.45M
Begining period cash
-81.26%1.33B
1,831.19%7.1B
--7.1B
408.56%367.81M
818.27%72.32M
--7.88M
Cash at the end
86.60%1.56B
-81.26%1.33B
--834.69M
1,831.19%7.1B
408.56%367.81M
--72.32M
Cash balance analysis
Cash and cash equivalent balance
--0
--0
--0
--0
--0
--0
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
IAS
IAS
IAS
IAS
IAS
IAS
Audit Opinions
--
Unqualified Opinion
--
Unqualified Opinion
Unqualified Opinion
Unqualified Opinion
Auditor
--
Ernst & Young
--
Ernst & Young
Ernst & Young
Ernst & Young
(Q6)Jun 30, 2023(FY)Dec 31, 2022(Q6)Jun 30, 2022(FY)Dec 31, 2021(FY)Dec 31, 2020(FY)Dec 31, 2019
Cash flow from operating activities
Earning before tax 51.16%775.58M21.05%1.18B--513.09M-0.03%972.92M43.76%973.24M--677M
Profit adjustment
Interest (income) - adjustment -256.57%-23.76M-39.87%-13.16M---6.66M4.80%-9.41M38.93%-9.88M---16.18M
Impairment and provisions: 157.66%316K139.29%469K---548K110.72%196K-216.20%-1.83M--1.57M
-Impairmen of inventory (reversal) 261.60%648K-11.54%-145K---401K-120.00%-130K18.18%650K--550K
-Impairment of trade receivables (reversal) -6.31%-337K-402.08%-145K---317K-80.41%48K-25.30%245K--328K
-Other impairments and provisions -97.06%5K173.02%759K--170K110.21%278K-491.38%-2.72M--696K
Revaluation surplus: -391.41%-15.19M157.21%8.28M--5.21M90.65%-14.47M-95,441.98%-154.78M---162K
-Other fair value changes -391.41%-15.19M157.21%8.28M--5.21M90.65%-14.47M-95,441.98%-154.78M---162K
Asset sale loss (gain): -16.95%2.37M1,501.10%2.91M--2.86M-21.55%182K4,540.00%232K--5K
-Loss (gain) on sale of property, machinery and equipment -16.95%2.37M720.85%2.91M--2.86M53.02%355K4,540.00%232K--5K
-Loss (gain) from selling other assets ---------------173K--------
Depreciation and amortization: 21.00%16.87M14.12%27.63M--13.94M8.61%24.21M24.66%22.29M--17.88M
-Depreciation 21.88%16.13M14.41%26.2M--13.24M8.54%22.9M25.50%21.09M--16.81M
-Amortization of intangible assets 4.55%735K9.06%1.43M--703K9.77%1.31M11.45%1.2M--1.07M
Financial expense --57K--21K----------------
Exchange Loss (gain) -904.39%-15.04M166.86%14.45M--1.87M---21.61M--------
Special items 26.47%10.43M7.13%17.66M--8.25M2,684.97%16.49M--592K----
Operating profit before the change of operating capital 39.71%751.63M27.62%1.24B--538.01M16.71%968.5M22.02%829.87M--680.11M
Change of operating capital
Inventory (increase) decrease 54.41%-3.24M-283.44%-94.36M---7.12M-70.38%-24.61M-50.53%-14.44M---9.6M
Accounts receivable (increase)decrease -333.20%-21.26M67.43%-3.64M--9.12M-112.96%-11.16M293.19%86.12M---44.58M
Accounts payable increase (decrease) 389.98%55.53M292.22%31.3M--11.33M-134.11%-16.28M92.49%47.74M--24.8M
prepayments (increase)decrease 108.91%11.16M-219.48%-61.75M---125.18M-309.23%-19.33M-84.70%9.24M--60.37M
Cash  from business operations 89.45%794.18M21.27%1.1B--419.21M-4.67%910.66M33.42%955.26M--715.96M
Other taxs 6.04%-101.29M20.87%-172.7M---107.8M-80.18%-218.26M-103.57%-121.13M---59.51M
Special items of business 105.34%372K-123.87%-3.23M---6.96M514.93%13.54M-167.22%-3.26M--4.85M
Net cash from operations 122.50%692.9M34.55%931.64M--311.41M-16.99%692.4M27.06%834.12M--656.46M
Cash flow from investment activities
Interest received - investment 256.57%23.76M39.87%13.16M--6.66M-4.80%9.41M-38.93%9.88M--16.18M
Loan receivable (increase) decrease -------------13.33%201.31M1,364.34%232.27M--15.86M
Sale of fixed assets --50K--------------------
Purchase of fixed assets -338.82%-186.96M-103.55%-152.66M---42.61M0.67%-75M11.66%-75.51M---85.47M
Selling intangible assets --------------16.53M--------
Purchase of intangible assets ----98.38%-586K---526K-4,286.91%-36.19M97.20%-825K---29.44M
Sale of subsidiaries --33.13M--------------------
Recovery of cash from investments 5.25%603.92M-72.44%1.48B--573.81M22.17%5.37B346.80%4.4B--984.2M
Cash on investment -32.70%-946.3M43.97%-2.2B---713.1M22.80%-3.93B-240.96%-5.08B---1.49B
Net cash from investment operations -168.78%-472.4M-154.93%-858.74M---175.76M399.98%1.56B11.65%-521.12M---589.85M
Net cash before financing 62.55%220.49M-96.77%72.9M--135.65M620.65%2.26B369.90%313.01M--66.61M
Cash flow from financing activities
Issuing shares ----1,023,592.98%583.51M------57K--------
Dividends paid - financing ----85.59%-367.46M---367.46M-169,335.22%-2.55B---1.51M----
Absorb investment income -98.35%4M-96.53%245.89M--241.89M78,723.44%7.09B50.00%9M--6M
Issuance expenses and redemption of securities expenses 99.80%-12.44M-1,990,828.66%-6.25B---6.24B---314K--------
Other items of the financing business ---531K99.73%-186K-----173.04%-68.31M-206.44%-25.02M---8.16M
Net cash from financing operations 99.86%-8.98M-229.36%-5.79B---6.36B25,640.97%4.48B-709.75%-17.52M---2.16M
Effect of rate 135.33%15.04M-1,485.12%-55.18M---42.57M--3.98M--------
Net Cash 103.40%211.52M-184.93%-5.72B---6.23B2,178.04%6.73B358.49%295.48M--64.45M
Begining period cash -81.26%1.33B1,831.19%7.1B--7.1B408.56%367.81M818.27%72.32M--7.88M
Cash at the end 86.60%1.56B-81.26%1.33B--834.69M1,831.19%7.1B408.56%367.81M--72.32M
Cash balance analysis
Cash and cash equivalent balance --0--0--0--0--0--0
Currency Unit CNYCNYCNYCNYCNYCNY
Accounting Standards IASIASIASIASIASIAS
Audit Opinions --Unqualified Opinion--Unqualified OpinionUnqualified OpinionUnqualified Opinion
Auditor --Ernst & Young--Ernst & YoungErnst & YoungErnst & Young

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
HK
Overall
Symbol
Latest Price
%Chg